SG Americas Securities’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

SG Americas Securities’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,475	Closed	-$94K	–	3673
2021 Q4	$94K	Sell	30,475 -32,134	-51%	-$108K	﹤0.01%	3100
2021 Q3	$226K	Buy	+62,609	New	+$236K	﹤0.01%	3152
2020 Q3	–	Sell	-47,372	Closed	-$207K	–	3844
2020 Q2	$207K	Buy	47,372 +15,761	+50%	+$70.8K	﹤0.01%	2837
2020 Q1	$120K	Buy	31,611 +18,203	+136%	+$89.4K	﹤0.01%	2872
2019 Q4	$85K	Buy	+13,408	New	+$78.8K	﹤0.01%	2987
2015 Q4	–	Sell	-10,628	Closed	-$59K	–	3254
2015 Q3	$59K	Buy	+10,628	New	+$78.4K	﹤0.01%	1949

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

SG Americas Securities's BDSI Position: Q1 2022 in Review

SG Americas Securities sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 30,475 shares — an estimated $94K sold.

SG Americas Securities first reported a position in BDSI in Q3 2015 and held it in 6 quarters. The position peaked at $226K in Q3 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

SG Americas Securities reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
SG Americas Securities sold 30,475 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $94K.
SG Americas Securities first reported a position in BioDelivery Sciences International, Inc. in Q3 2015 and held it in 6 quarters.
SG Americas Securities's BioDelivery Sciences International, Inc. position peaked at $226K in Q3 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.